Ryan Specialty Group (RYAN) Releases IPO Terms, Stock Looks Promising

Ryan Specialty Group (RYAN) has revealed the terms for its IPO. Is its valuation attractive, and should you buy the stock?

Ambrish Shah - Author
By

Jul. 20 2021, Published 8:41 a.m. ET

Ryan Specialty Group graphic, Earth in background
Source: Ryan Specialty Group Twitter

Ryan Specialty Group (RYAN) has disclosed the terms for its IPO. The company plans to raise about $1.3 billion in the offering. Is RYAN IPO stock a good buy for investors? What can investors expect following the IPO?

Article continues below advertisement
Article continues below advertisement

Ryan Specialty is a wholesale specialty insurance brokerage offering MGU (marketing general underwriter) services. The company is growing its revenue impressively, and is profitable on an annual basis. Ryan Specialty has received $658 million in equity investments from founder, chairman, and CEO Patrick Ryan and Onex RSG Holdings.

Ryan Specialty Group's IPO date and price

Ryan Specialty hasn’t officially revealed its IPO date yet, but several reports indicate that it could come as early as Jul. 22. Ryan Specialty plans to offer 56.9 million shares at $22 to $25 per share. JPMorgan Chase, Barclays, Goldman Sachs, and Wells Fargo are the underwriters for the IPO. The underwriters have the option to purchase an additional 8.5 million shares at the IPO price.

Article continues below advertisement
should i buy ryan specialty group ipo
Source: Ryan Specialty Group Twitter

Ryan Specialty Group is profitable

Ryan Specialty reported a net income of $70.5 million in 2020, compared with $63.1 million in 2019. Its revenue rose 33.1 percent YoY (year-over-year) to $1 billion in 2020 and 49.6 percent YoY to $311.5 million in the first quarter of 2021. As of Mar. 31, 2021, the company had $3.9 billion in total liabilities and $159.2 million in cash and cash equivalents.

Article continues below advertisement
Article continues below advertisement
should i buy ryan specialty group ipo
Source: Ryan Specialty Group Twitter

RYAN stock's valuation

The IPO will value Ryan Specialty at $6 billion, and its terms put the company’s 2020 price-to-sales multiple at 6x. While that multiple might look high in absolute terms, Ryan Specialty is a high-growth stock and its revenue should increase significantly in the coming years. Aon and Lemonade are trading at next-12-month EV-to-sales multiples of 4.9x and 29.6x, respectively.

Article continues below advertisement

RYAN’s stock price and ticker symbol

Ryan Specialty stock will trade under the ticker symbol “RYAN”. The stock will be listed on the NYSE, and the company is offering IPO shares at $22 to $25.

Article continues below advertisement
Article continues below advertisement

Ryan Specialty’s stock forecast

Ryan Specialty’s outlook looks promising. According to Insurance Business America, the E&S (excess and surplus lines) market in the U.S. is growing. E&S market premiums in 2020 totaled $41.7 billion, representing 15 percent YoY growth. The major drivers for this growth were low interest rates, higher claims costs, and severe weather occurrences.

RYAN IPO stock is a good buy

Ryan Specialty offers customized specialty insurance solutions for agents, brokers, and carriers in the E&S market. In the U.S., it's the second-largest property and casualty insurance wholesale broker and the third-largest P&C MGU. Ryan Specialty's distribution network of more than 650 producers gives the company access to over 15,500 retail insurance brokerage companies and over 200 carriers. The insurance company makes money through fees and commissions.

Article continues below advertisement
Article continues below advertisement

Ryan Specialty’s financials are impressive, demonstrating significant growth and historical profitability. At its reasonable price, the IPO is worth considering.

How to buy RYAN IPO stock

Ryan Specialty shares can be purchased using a traditional or online discount broker such as Robinhood.

Advertisement

Latest IPOs News and Updates

    Opt-out of personalized ads

    © Copyright 2024 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.